Dietary fructose-related adiposity and glucocorticoid receptor function in visceral adipose tissue of female rats

European Journal of Nutrition

Volumn 53, Issue 6, 2014, Pages 1409-1420

  Kovačević, Sanja ^a   Nestorov, Jelena ^a   Matić, Gordana ^a   Elaković, Ivana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

11 HSD1; Adiposity; Female rats; Fructose diet; Glucocorticoid receptor; Visceral adipose tissue

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CORTICOSTERONE; FATTY ACID; FRUCTOSE; GLUCOCORTICOID RECEPTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL LIPASE; CHOLESTEROL ESTERASE; GALACTOSE-6-PHOSPHATE DEHYDROGENASE; GLUCOCORTICOID; MESSENGER RNA; OXIDOREDUCTASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOSOL; DIETARY INTAKE; ENERGY BALANCE; FATTY ACID BLOOD LEVEL; FEMALE; FOOD INTAKE; HORMONE BINDING; INTRAABDOMINAL FAT; LIPOGENESIS; LIPOLYSIS; MICROSOME; NONHUMAN; NUCLEOSOME; OBESITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; DOWN REGULATION; DRUG EFFECTS; GENETICS; METABOLISM; WISTAR RAT;

RATTUS;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSITY; ANIMALS; CARBOHYDRATE DEHYDROGENASES; DOWN-REGULATION; ENERGY INTAKE; FATTY ACIDS, NONESTERIFIED; FEMALE; FRUCTOSE; GLUCOCORTICOIDS; INTRA-ABDOMINAL FAT; LIPOGENESIS; LIPOLYSIS; RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; STEROL ESTERASE; TRIGLYCERIDES;

EID: 84906940557     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-013-0644-1     Document Type: Article

References (68)

1. Bray GA, Nielsen SJ, Popkin BM (2004) Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79:537-543
2. Welsh JA, Sharma A, Abramson JL, Vaccarino V, Gillespie C, Vos MB (2010) Caloric sweetener consumption and dyslipidemia among US adults. JAMA 303:1490-1497
3. Perez-Pozo SE, Schold J, Nakagawa T, Sanchez-Lozada LG, Johnson RJ, Lillo JL (2010) Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond) 34:454-461
4. Le KA, Tappy L (2006) Metabolic effects of fructose. Curr Opin Clin Nutr Metab Care 9:469-475
5. Pijl H, Meinders AE (1996) Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Saf 14:329-342
6. Baid SK, Nieman LK (2006) Therapeutic doses of glucocorticoids: implications for oral medicine. Oral Dis 12:436-442 (Pubitemid 44252535)
7. Schacke H, Schottelius A, Docke WD, Strehlke P, Jaroch S, Schmees N, Rehwinkel H, Hennekes H, Asadullah K (2004) Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci USA 101:227-232 (Pubitemid 38084232)
8. Seckl JR, Walker BR (2001) Minireview: 11beta-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology 142:1371-1376 (Pubitemid 32299662)
9. Salehi M, Ferenczi A, Zumoff B (2005) Obesity and cortisol status. Horm Metab Res 37:193-197 (Pubitemid 40756337)
10. Walker BR, Andrew R (2006) Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease. Ann N Y Acad Sci 1083:165-184 (Pubitemid 44955472)
11. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM (2004) 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25:831-866 (Pubitemid 39366049)
12. Desbriere R, Vuaroqueaux V, Achard V, Boullu-Ciocca S, Labuhn M, Dutour A, Grino M (2006) 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Obesity (Silver Spring) 14:794-798 (Pubitemid 46219720)
13. Michailidou Z, Jensen MD, Dumesic DA, Chapman KE, Seckl JR, Walker BR, Morton NM (2007) Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity. Obesity (Silver Spring) 15:1155-1163 (Pubitemid 46932470)
14. Mariniello B, Ronconi V, Rilli S, Bernante P, Boscaro M, Mantero F, Giacchetti G (2006) Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome. Eur J Endocrinol 155:435-441 (Pubitemid 44463950)
15. Paulsen SK, Pedersen SB, Fisker S, Richelsen B (2007) 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity (Silver Spring) 15:1954-1960 (Pubitemid 47402227)
16. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170 (Pubitemid 33150673)
17. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS (2003) Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112:83-90 (Pubitemid 38056379)
18. Livingstone DE, Kenyon CJ, Walker BR (2000) Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats. J Endocrinol 167:533-539 (Pubitemid 32047561)
19. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR (2004) Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53:931-938 (Pubitemid 38436604)
20. Vegiopoulos A, Herzig S (2007) Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrinol 275:43-61 (Pubitemid 47259280)
21. Slavin BG, Ong JM, Kern PA (1994) Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes. J Lipid Res 35:1535-1541 (Pubitemid 24291214)
22. Franckhauser S, Munoz S, Pujol A, Casellas A, Riu E, Otaegui P, Su B, Bosch F (2002) Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes 51:624-630 (Pubitemid 34760168)
23. Gaillard D, Wabitsch M, Pipy B, Negrel R (1991) Control of terminal differentiation of adipose precursor cells by glucocorticoids. J Lipid Res 32:569-579
24. Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F (2004) SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86:839-848 (Pubitemid 39602764)
25. Fajas L, Debril MB, Auwerx J (2001) PPAR gamma: an essential role in metabolic control. Nutr Metab Cardiovasc Dis 11:64-69 (Pubitemid 33687794)
26. Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288:1723-1727
27. Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH (2002) Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 288:1758-1761
28. Tonstad S, Sandvik E, Larsen PG, Thelle D (2007) Gender differences in the prevalence and determinants of the metabolic syndrome in screened subjects at risk for coronary heart disease. Metab Syndr Relat Disord 5:174-182 (Pubitemid 46954302)
29. Beigh SH, Jain S (2012) Prevalence of metabolic syndrome and gender differences. Bioinformation 8:613-616
30. Duncombe WG (1964) The colorimetric micro-determination of non-esterified fatty acids in plasma. Clin Chim Acta 9:122-125
31. Elaković I, Nestorov J, Kovačević S, Matić G (2012) Selection of reference genes for normalization of real time PCR data in visceral adipose tissue of female rats on fructose enriched diet. Arch Biol Sci 64:1247-1259
32. Alzamendi A, Castrogiovanni D, Ortega HH, Gaillard RC, Giovambattista A, Spinedi E (2010) Parametrial adipose tissue and metabolic dysfunctions induced by fructose-rich diet in normal and neonatal-androgenized adult female rats. Obesity (Silver Spring) 18:441-448
33. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ (2009) Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119:1322-1334
34. Rosewicz S, McDonald AR, Maddux BA, Goldfine ID, Miesfeld RL, Logsdon CD (1988) Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem 263:2581-2584 (Pubitemid 18062893)
35. Burnstein KL, Jewell CM, Sar M, Cidlowski JA (1994) Intragenic sequences of the human glucocorticoid receptor complementary DNA mediate hormone-inducible receptor messenger RNA down-regulation through multiple mechanisms. Mol Endocrinol 8:1764-1773
36. Dong Y, Poellinger L, Gustafsson JA, Okret S (1988) Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranslational mechanisms. Mol Endocrinol 2:1256-1264 (Pubitemid 19005938)
37. McIntyre WR, Samuels HH (1985) Triamcinolone acetonide regulates glucocorticoid-receptor levels by decreasing the half-life of the activated nuclear-receptor form. J Biol Chem 260:418-427 (Pubitemid 15164067)
38. Veilleux A, Laberge PY, Morency J, Noel S, Luu-The V, Tchernof A (2010) Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue. J Steroid Biochem Mol Biol 122:28-34
39. London E, Castonguay TW (2011) High fructose diets increase 11beta-hydroxysteroid dehydrogenase type 1 in liver and visceral adipose in rats within 24-h exposure. Obesity (Silver Spring) 19:925-932
40. Morton NM, Ramage L, Seckl JR (2004) Down-regulation of adipose 11beta-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease. Endocrinology 145:2707-2712 (Pubitemid 38686218)
41. Froesch ER, Ginsberg JL (1962) Fructose metabolism of adipose tissue. I. Comparison of fructose and glucose metabolism in epididymal adipose tissue of normal rats. J Biol Chem 237:3317-3324
42. Senesi S, Legeza B, Balazs Z, Csala M, Marcolongo P, Kereszturi E, Szelenyi P, Egger C, Fulceri R, Mandl J, Giunti R, Odermatt A, Banhegyi G, Benedetti A (2010) Contribution of fructose-6-phosphate to glucocorticoid activation in the endoplasmic reticulum: possible implication in the metabolic syndrome. Endocrinology 151:4830-4839
43. Necela BM, Cidlowski JA (2004) Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells. Proc Am Thorac Soc 1:239-246
44. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911-919; quiz 920
45. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91 (Pubitemid 23036092)
46. Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, Mooney RA (2003) Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem 278:13740-13746 (Pubitemid 36799910)
47. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M, Stewart PM (2001) Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 142:1982-1989 (Pubitemid 32405956)
48. Rondinone CM, Rodbard D, Baker ME (1993) Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes. Endocrinology 132:2421-2426 (Pubitemid 23156890)
49. Hirata A, Maeda N, Hiuge A, Hibuse T, Fujita K, Okada T, Kihara S, Funahashi T, Shimomura I (2009) Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice. Cardiovasc Res 84:164-172
50. Caprio M, Feve B, Claes A, Viengchareun S, Lombes M, Zennaro MC (2007) Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J 21:2185-2194 (Pubitemid 47026453)
51. Hoppmann J, Perwitz N, Meier B, Fasshauer M, Hadaschik D, Lehnert H, Klein J (2010) The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses. J Endocrinol 204:153-164
52. Bujalska IJ,Kumar S, Stewart PM(1997)Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349:1210-1213 (Pubitemid 27190044)
53. Yang K, Khalil MW, Strutt BJ, Killinger DW (1997) 11 beta-hydroxysteroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: effect on aromatase activity. J Steroid Biochem Mol Biol 60:247-253 (Pubitemid 27229780)
54. Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Heintze U, Janke J, Luft FC, Sharma AM (2004) Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res 12:9-17 (Pubitemid 41137482)
55. Milagro FI, Campion J, Martinez JA (2007) 11-Beta hydroxysteroid dehydrogenase type 2 expression in white adipose tissue is strongly correlated with adiposity. J Steroid Biochem Mol Biol 104:81-84 (Pubitemid 46412989)
56. Pratt WB, Toft DO (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18:306-360 (Pubitemid 27246880)
57. Simons SS Jr, Pratt WB (1995) Glucocorticoid receptor thiols and steroid-binding activity. Methods Enzymol 251:406-422
58. Farina JP, Garcia ME, Alzamendi A, Giovambattista A, Marra CA, Spinedi E, Gagliardino JJ (2013) Antioxidant treatment prevents the development of fructose-induced abdominal adipose tissue dysfunction. Clin Sci (Lond) 125:87-97
59. Rebolledo OR, Marra CA, Raschia A, Rodriguez S, Gagliardino JJ (2008) Abdominal adipose tissue: early metabolic dysfunction associated to insulin resistance and oxidative stress induced by an unbalanced diet. Horm Metab Res 40:794-800 (Pubitemid 352777248)
60. Moreno JA, Hong E (2012) A single oral dose of fructose induces some features of metabolic syndrome in rats: role of oxidative stress. Nutr Metab Cardiovasc Dis 23:536-542
61. Grad I, Picard D (2007) The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrinol 275:2-12 (Pubitemid 47260713)
62. Okamoto K, Tanaka H, Ogawa H, Makino Y, Eguchi H, Hayashi S, Yoshikawa N, Poellinger L, Umesono K, Makino I (1999) Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 274:10363-10371
63. Langin D, Holm C, Lafontan M (1996) Adipocyte hormone-sensitive lipase: a major regulator of lipid metabolism. Proc Nutr Soc 55:93-109 (Pubitemid 126795326)
64. Forest C, Tordjman J, Glorian M, Duplus E, Chauvet G, Quette J, Beale EG, Antoine B (2003) Fatty acid recycling in adipocytes: a role for glyceroneogenesis and phosphoenolpyruvate carboxykinase. Biochem Soc Trans 31:1125-1129 (Pubitemid 38030922)
65. Bursac BN, Djordjevic AD, Vasiljevic AD, Milutinovic DD, Velickovic NA, Nestorovic NM, Matic GM (2013) Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue. J Nutr Biochem 24:1166-1172
66. Bourke CH, Harrell CS, Neigh GN (2012) Stress-induced sex differences: adaptations mediated by the glucocorticoid receptor. Horm Behav 62:210-218
67. Krishnan AV, Swami S, Feldman D (2001) Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol 77:29-37 (Pubitemid 32455350)
68. Ferrini M, Lima A, De Nicola AF (1995) Estradiol abolishes autologous down regulation of glucocorticoid receptors in brain. Life Sci 57:2403-2412